Functional/Serologic Test
3002
ABO and Rh
Testing for pretransfusion donor and patient compatibility and to assist in the diagnosis
2200
ABO and Rh - Transplant
Testing for donor and patient compatibility in the context of a organ or bone marrow transplant
3024
ABO Antibody Titer
ABO antibody titration tests for the assessment of prognosis in ABO-incompatible hematopoietic stem cell transplantation or for decision-making in ABO-incompatible kidney transplantation.
1298
ADAMTS13 Activity
This assay is measured by Fluorescence Resonance Energy Transfer (FRET) with a synthetic substrate.
1295
ADAMTS13 Evaluation
ADAMTS13 Evaluation is a reflexive testing algorithm for evaluation of TTP. Activity is always performed. If result is <= 30%, the inhibitor assay (1297) is performed. If inhibitor result is <= 0.7 Inhibitor Units, the antibody assay (1299) is performed
1297
ADAMTS13 Inhibitor
The inhibitor assay measures antibodies that inhibit ADAMTS13 function by mixing study.
3060
Antibody Identification Workup
ABO/Rh, Direct Antiglobulin Test and one Ab ID. Based on results determined by IRL, additional tests may include selected cell panel(s), selected cell screens(s), rare cell panel(s), and pertinent antigen typing(s).
3080
Antibody Titration Workup
Detects the presence and measures the amount of antibodies within a personÂ’s blood. Monitoring antibody levels during pregnancy to help assess the risk of hemolytic disease of the newborn (HDN).
1056
Anti-VWF Antibody IgG and IgM
This assay quantifies anti-VWF antibodies IgG and IgM using an ELISA plate method to support diagnosis of acquired von Willebrand disease.
3997
Autoimmune Hemolytic Anemia
Testing to determine when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation.
2600
Crossmatch (Flow Cytometry)
The flow cytometric lymphocyte crossmatch is a technique for evaluating the compatibility of potential transplant recipients and donors and analyzed for the presence of bound IgG antibodies.
2610
Crossmatch (Flow Cytometry) Against Recipient
Recipient serum is incubated with donor lymphocytes which are analyzed in a flow cytometer for the presence of bound IgG antibodies to find donor-specific antibodies to avoid deleterious graft function.
2601
Crossmatch (Flow Cytometry) Titration
Titration allows you to determine the amount of antibody that gives you the best separation of populations in your samples, and the best measure of expression levels.
3111
DAT Negative Hemolytic Anemia Evaluation
Includes: ABO/Rh, Direct Antiglobulin Tests (including IgA detection), Elution (routine and enhanced), and antibody detection tests (routine and enhanced). Additional tests as necessary based upon results determined by Immunohematology Reference Lab.
3009
Direct Antiglobulin Test (DAT)
Also known as the direct Coombs test, is used primarily to help determine whether the cause of hemolytic anemia.
3011
Donath-Landsteiner
Detects harmful antibodies related to a rare disorder called paroxysmal cold hemoglobinuria. Not available as an individual test. Requires initial evaluation at additional cost.
9500
Drug-Dependent Neutrophil Antibody
Test for antibodies in patientÂ’s serum that react against neutrophils only in the presence of a specific drug causing neutropenia.
9000
Drug-Dependent Platelet Antibody
This assay employs flow cytometric detection of drug-dependent platelet antibodies for several drugs.
3110
Drug-Dependent RBC Antibody Study
Evaluation of immune hemolysis after exposure to certain drugs is important in order to make the correct diagnosis and to prevent possible future adverse complications.Not available as an individual test. Requires initial evaluation at additional cost.
3020
Elution
Used for dissociating an antibody that is attached to the surface of a red blood cell. Used in identification of complicated antibodies, the workup of transfusion reactions or hemolytic disease of the newborn, and the workup of warm autoantibodies.
1025
Factor II Inhibitor Profile
This order includes both Factor II Activity and Factor II Inhibitor.
1093
Factor IX Activity - Hepzyme Treated
This assay measures activity of factor IX, with addition of hepzyme to neutralize the influence of heparin.
1095
Factor IX Inhibitor Profile
This order set includes both Factor IX Activity and Factor IX Inhibitor.
1094
Factor IX Inhibitor Profile - Hepzyme Treated
This order set includes both Factor IX Activity and Factor IX Inhibitor, both including the addition of hepzyme to neutralize the influence of heparin.
1055
Factor V Inhibitor Profile
This order set includes both Factor V Activity and Factor V Inhibitor.
1075
Factor VII Inhibitor Profile
This profile includes: Factor VII Activity and Factor VII Inhibitor.
1135
Factor VIII Activity - Chromogenic
The chromogenic factor VIII activity assay uses bovine reagents, is insensitive to emicizumab and lupus anticoagulant, and is adversely affected by the presence of direct factor X inhibitors or high concentrations of heparin.
1081
Factor VIII Activity - Clot based
This test measures the activity of factor VIII to aid in diagnosis of hemophilia A, acquired factor VIII deficiency, or as part of diagnostic workup for von Willebrand disease (VWD).
1315
Factor VIII Activity - Concentrate
This test is used to determine the level of the coagulation protein Factor VIII in a vial of factor concentrate.
1310
Factor VIII Activity - Cryoprecipitate
This test is used to determine the level of the coagulation protein Factor VIII in a unit or pool of cryoprecipitate. Contact laboratory for additional information.
1136
Factor VIII Activity Hepzyme Treated - Chromogenic
The chromogenic factor VIII activity assay uses bovine reagents, is insensitive to emicizumab and lupus anticoagulant, and is adversely affected by the presence of direct factor X inhibitors or very high concentrations of heparin (greater than 2 U/mL). The addition of hepzyme in this assay will neutralize the influence of heparin.
1082
Factor VIII Activity Hepzyme Treated - Clot based
This assay measures activity of factor VIII, with addition of hepzyme to neutralize the influence of heparin.
1137
Factor VIII Inhibitor
The chromogenic factor VIII inhibitor assay uses bovine reagents, is insensitive to emicizumab and lupus anticoagulant, and is adversely affected by the presence of direct factor X inhibitors or high concentrations of heparin.
1138
Factor VIII Inhibitor - Hepzyme Treated
The chromogenic factor VIII inhibitor assay uses bovine reagents, is insensitive to emicizumab and lupus anticoagulant, and is adversely affected by the presence of direct factor X inhibitors or very high concentrations of heparin (greater than 2 U/mL). The addition of hepzyme in this assay will neutralize the influence of heparin.
1115
Factor XI Inhibitor Profile
This order set includes: Factor XI Activity and Factor XI Inhibitor.
1125
Factor XII Inhibitor Profile
This order set includes: Factor XII Activity and Factor XII Inhibitor.
1011
Fibrinogen Activity
This assay measures fibrinogen activity. Versiti is temporarily unable to report a Fibrinogen Activity:Fibrinogen Antigen ratio or provide an interpretation when both the Fibrinogen Activity Assay (Order Code: 1011) and Fibrinogen Antigen Assay (Order Code: 1508) are ordered.
1320
Fibrinogen Activity - Cryoprecipitate
This test is used to determine the level of the coagulation protein Fibrinogen in a unit or pool of cryoprecipitate. Contact laboratory for additional information.
1012
Fibrinogen Antigen - TEMPORARILY UNAVAILABLE
Effective October 23, 2023, and until we can validate a new in-house assay, any samples received for the Fibrinogen Antigen Assay (Order Code 1012) will be passed through, processed, and resulted by our send-out partner, ARUP. For information about the pass-through Fibrinogen Antigen Assay, refer to order code 1508.
1508
Fibrinogen Antigen - Plasma
Samples received for this assay are passed through, processed, and resulted by our send-out partner, ARUP. We are unable to hold or return samples, should you prefer your samples NOT be passed through.
5444
Glycoprotein IV (CD36) Typing
This assay utilizes flow cytometry in the typing of platelet glycoprotein IV (CCD36).
3100
Hemolytic Disease of the Newborn (HDN)
Serological analysis post-delivery to determine compatibility of mother and baby when Hemolytic Disease of the Newborn is suspected.
5514
Heparin-Dependent Platelet Antibody (PF4 ELISA) - IgA/M Panel
This Platelet Factor Four Enzyme Linked Immunosorbent Assay is designed for detection of Heparin-Dependent Platelet Antibodies of the IgM or IgA subclasses.
5510
Heparin-Dependent Platelet Antibody (PF4 ELISA) - IgG
This Platelet Factor Four Enzyme Linked Immunosorbent Assay is designed for detection of Heparin-Dependent Platelet Antibodies of the IgG subclass.
5502
Heparin-Induced Thrombocytopenia - PEA
This test is designed to detect heparin-dependent platelet antibodies in the serum from patients suspected of having Heparin-Induced Thrombocytopenia (HIT).
5508
Heparin-Induced Thrombocytopenia - SRA
This test is designed to detect heparin-dependent platelet antibodies in the serum from patients suspected of having Heparin-Induced Thrombocytopenia (HIT).
5509
Heparin-Induced Thrombocytopenia Evaluation (SRA)
Heparin-Induced Thrombocytopenia Evaluation is a reflexive algorithm. IgG-PF4 ELISA is always performed. If ELISA results are non-negative a Serotonin Release Assay will be performed.
2235
HLA Antibody Detection (Flow Cytometry)
HLA antigen testing for solid organ and stem cell transplants.
5002
HOLD TRALI Recipient
Versiti Wisconsin, Inc will HOLD a recipient whole blood sample during TRALI donor testing. If an antibody is identified in the donor, the recipient sample could be genotyped to confirm presence of the target antigen by client's request.
5126
Neonatal Alloimmune Neutropenia (NAN) Panel - Father
This panel includes: Neutrophil Antigen Genotyping - HNA-1, 3, 4 and 5.
5125
Neonatal Alloimmune Neutropenia (NAN) Panel - Mother
This panel includes: Neutrophil Antigen Genotyping - HNA-1, 3, 4 and 5, and Neutrophil Antibody Identification and HLA Antibody Screen.
5703
Neonatal Alloimmune Thrombocytopenia (NAIT)-Initial Paternal
This order set includes: Platelet Antigen Genotyping Panel. To complete this workup, order Neonatal Alloimmune Thrombocytopenia (NAIT)-Initial Testing Maternal with Paternal (test code 5603) for maternal sample.
5303
Neonatal Alloimmune Thrombocytopenia (NAIT)-Initial Testing Maternal Only
This order set includes: Platelet Antigen Genotyping Panel and Platelet Antibody Identification Panel. Order this test when the father is not available for testing.
5603
Neonatal Alloimmune Thrombocytopenia (NAIT)-Initial Testing Maternal with Paternal
This order set includes: Platelet Antigen Genotyping on parents, Platelet Antibody Identification Panel on mother and maternal serum crossmatched with paternal platelets. To complete the workup, concurrently order NAIT-Initial Paternal (test code 5703)
5630
Neonatal Alloimmune Thrombocytopenia (NAIT)-Serial Monitoring Maternal only
This assay includes: Testing for antibodies against HPA-1a/b, HPA-2a/b, HPA-3a/b, HPA-4a, HPA-5a/b, GPIIb/IIIa, GPIa/IIa, GPIb/IX. GPIV and Class I HLA.
5640
Neonatal Alloimmune Thrombocytopenia (NAIT)-Serial Monitoring Maternal with Paternal
This order set includes: Platelet Antibody Identification Panel on mother and maternal serum crossmatched with paternal platelets.
5113
Neutrophil Antibody Identification and HLA Antibody Screen
This order set includes: Neutrophil Antibody Identification and HLA Antibody Detection.
5102
Neutrophil Antibody Screen
This flow-cytometry screen tests for the detection and identification of neutrophil antibodies.
5112
Neutrophil Antibody Screen and HLA Antibody Screen
This order set includes: Neutrophil Antibody Screen and HLA Antibody Detection. Automatic reflexing options are available.
5119
Neutrophil Antibody Screen with REFLEX to 5113 (Neut ID and HLA Screen)
This order will automatically reflex to Neutrophil Antibody Identification and HLA Detection if neutrophil reactive antibodies are detected.
5110
Neutrophil Antibody Screen with REFLEX to HLA Antibody Screen
This order will automatically reflex to HLA Detection if neutrophil reactive antibodies are detected.
3240
Partial RhD Analysis
Mutations in RHD may result in amino acid substitutions in the D protein. If those substances change the appearance or structure of exposed parts of the antigen on the outside of the RBC (epitopes), the patient is described as having partial D.
1175
Platelet Aggregation
Used to assess platelet function if a hereditary bleeding disorder is suspected. Includes: Aggregation with Ristocetin; Aggregation and ATP Release w/ ADP, Collagen, Thrombin and Arachidonic Acid. Platelets must be tested within four (4) hours of draw. To order testing, use the Platelet Aggregation Form
5608
Platelet Antibody Identification Panel
This panel includes: Testing for antibodies against HPA-1a/b, HPA-2a/b, HPA-3a/b, HPA-4a, HPA-5a/b, GPIIb/IIIa, GPIa/IIa, GPIb/IX, GPIV and Class I HLA.
5543
Platelet Antibody Screen
This assay screens patient sera for platelet-reactive antibodies via flow cytometry.
5544
Platelet Autoantibodies
This assay detects direct and indirect glycoprotein-specific antibodies in eluates prepared from washed patient platelets.
5545
Platelet Glycoprotein Expression (PGE)
This order includes: GPIb (Bernard Soulier Syndrome) and GPIIb/IIIa (Glanzmann Thrombasthenia).
5632
Platelet Transfusion Refractory (PTR) Panel
This panel includes: Platelet Antibody Identification Panel and Platelet Antigen Genotyping Panel.
5550
PNH - Erythrocytes and Leukocytes
Flow cytometric evaluation of both erythrocytes and leukocytes in evaluation for paroxysmal nocturnal hemoglobinuria (PNH)
5549
PNH - Leukocytes
Flow cytometric evaluation of leukocytes in evaluation for paroxysmal nocturnal hemoglobinuria (PNH)
1086
Porcine Factor VIII Inhibitor Profile
This order set includes both Factor VIII Activity-Clot based and Porcine Factor VIII Inhibitor.
1084
Porcine Factor VIII Inhibitor Profile - Hepzyme Treated
This order set includes both Factor VIII Activity-Clot based and Porcine Factor VIII Inhibitor, with addition of hepzyme to neautralize the influence of heparin
5631
Post-Transfusion Purpura (PTP) Panel
Includes: Platelet Antibody Identification Panel and Platelet Antigen Genotyping Panel.
1031
Protein C Activity
This test provides the activity level of the blood coagulation factor, Protein C. This protein is one of the regulatory proteins in the blood clotting cascade.
1033
Protein C Antigen
This test provides the antigen level of the blood coagulation factor, Protein C. This protein is one of the regulatory proteins in the blood clotting cascade.
1041
Protein S Activity
This test provides the activity level of the blood coagulation factor, Protein S. This protein is one of the regulatory proteins in the blood clotting cascade.
1043
Protein S Antigen, Free
This test provides the antigen level of the blood coagulation factor, Protein S. This protein is one of the regulatory proteins in the blood clotting cascade.
1042
Protein S Antigen, Total and Free
This test provides the antigen level of the blood coagulation factor, Protein S. This protein is one of the regulatory proteins in the blood clotting cascade.
1068
Ristocetin-Induced Platelet Aggregation (RIPA)
Aggregation with high and low dose ristocetin is used to identify patients with type 2B von Willebrand Disease, platelet-type von Willebrand Disease or Bernard-Soulier Syndrome. Platelet Aggregation Form
1260
Single Platelet Agonist Aggregation - ADP
Used to assess platelet function if a hereditary bleeding disorder is suspected. This test is used to determine how a patients platelets respond to the agonist ADP. Patients platelets must be tested within four (4) hours of draw. To order testing, use the Platelet Aggregation Form
1255
Single Platelet Agonist Aggregation - Arachidonic Acid
Used to assess platelet function if a hereditary bleeding disorder is suspected. This test is used to determine how a patients platelets respond to the agonist AA. Patients platelets must be tested within four (4) hours of draw. To order testing, use the Platelet Aggregation Form
1270
Single Platelet Agonist Aggregation - Collagen
Used to assess platelet function if a hereditary bleeding disorder is suspected. This test is used to determine how a patients platelets respond to the agonist collagen. Patients platelets must be tested within four (4) hours of draw.
1250
Single Platelet Agonist Aggregation - Thrombin
Used to assess platelet function if a hereditary bleeding disorder is suspected. This test is used to determine how a patients platelets respond to the agonist Thrombin. Patients platelets must be tested within four (4) hours of draw. To order testing, use the Platelet Aggregation Form
3021
Thermal Amplitude Study
Not available as an individual test. Requires initial evaluation at additional cost.
5506
Vaccine-Induced Immune Thrombotic Thrombocytopenia - SRA Panel
This SRA Panel includes testing with and without heparin.
5515
VITT Workup (PF4 IgG - Reflex to VITT SRA Panel)
VITT Workup is a reflexive algorithm. IgG-PF4 ELISA is always performed. If ELISA results are non-negative Serotonin Release Assays with and without heparin will be performed.
1800
VWD Diagnostic Evaluation
Reflexive algorithm always includes: FVIII Activity, VWF Antigen, VWF GPIbM Activity, and VWF Collagen III Binding. Reflex testing may include: VWD Type 2B Binding, VWD Type 2N Binding, VWF Propeptide Antigen, and/or VWF Quantitative Multimer
1215
VWD Monitoring Profile
Includes Factor VIII Activity - Clot based, VWF Antigen, and VWF GPIbM Activity.
1067
VWD Type 2B Evaluation
This order set includes VWD Type 2B Binding and VWD Type 2B Quantitative Multimer.
1089
VWD Type 2N Binding
This 2N-von Willebrand Disease panel is designed to distinguish type 2N-von Willebrand disease from mild hemophilia A and hemophilia A carriers.
1088
VWD Type 2N Profile
This order set includes: Factor VIII Activity, VWF Antigen and VWD Type 2N Binding.
1062
VWF Antigen
This assay measures a patient's total vWF protein level, independent of the multimer composition of the plasma
1279
VWF Collagen Binding Profile
This assay tests the capacity of platelet adhesion at sites of blood vessel injury and can identify qualitative binding issues. Includes VWF Antigen, VWF Collagen III Binding, and VWF Collagen IV Binding. Additional reflex to VWF Quantitative Multimer, if indicated.
1281
VWF Collagen III Binding
This assay tests the capacity of platelet adhesion at sites of blood vessel injury and can identify qualitative binding issues.
1280
VWF Collagen IV Binding
This assay tests the capacity of platelet adhesion at sites of blood vessel injury and can identify qualitative binding issues.
1070
VWF GPIbM Activity
This ristocetin-independent activity assay is an alternative to VWF Ristocetin Cofactor Activity with superior precision and sensitivity.
1065
VWF Inhibitor Profile
This order set includes VWF Inhibitor Screen mixing study and VWF GPIbM Activity. If the VWF GPIbM result is >= 50 IU/dL, the inhibitor screen is invalid and will be cancelled and credited.
1282
VWF Propeptide Antigen
This assay evaluates propeptide antigen levels. This result should be correlated with VWF antigen, VWF ristocetin cofactor activity, VWF multimers, and clinical history by the ordering physician to arrive at the appropriate diagnosis.
1063
VWF Quantitative Multimer
Quantitative multimer analysis provides an objective measure of VWF structure to characterize subtle changes observed in the subtypes of VWD and may help to determine the nature of any additional clinical laboratory testing to reach a clear-cut diagnosis
3040
Weak RhD Analysis Workup
This complex test is ordered to resolve a Rh discrepancy (aka D antigen typing discrepancy). The molecular testing will identify Weak D Types 1, 2, and 3. These Weak D Types can be safely deemed Rh positive.